On Friday, Insmed Inc (NASDAQ: INSM) opened higher 0.38% from the last session, before settling in for the closing price of $76.29. Price fluctuations for INSM have ranged from $21.92 to $80.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 22.42%. Company’s average yearly earnings per share was noted -0.32% at the time writing. With a float of $174.62 million, this company’s outstanding shares have now reached $178.85 million.
Let’s determine the extent of company efficiency that accounts for 912 employees. In terms of profitability, gross margin is 76.51%, operating margin of -214.11%, and the pretax margin is -251.01%.
Insmed Inc (INSM) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Insmed Inc is 2.39%, while institutional ownership is 106.07%. The most recent insider transaction that took place on Jan 30 ’25, was worth 7,291,200. In this transaction Chief People Strategy Officer of this company sold 91,140 shares at a rate of $80.00, taking the stock ownership to the 97,083 shares. Before that another transaction happened on Jan 30 ’25, when Company’s Officer proposed sale 91,140 for $80.00, making the entire transaction worth $7,291,200.
Insmed Inc (INSM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.82% during the next five years compared to -4.82% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Check out the current performance indicators for Insmed Inc (INSM). In the past quarter, the stock posted a quick ratio of 5.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 39.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.56, a number that is poised to hit -1.16 in the next quarter and is forecasted to reach -4.34 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Looking closely at Insmed Inc (NASDAQ: INSM), its last 5-days average volume was 1.86 million, which is a drop from its year-to-date volume of 2.0 million. As of the previous 9 days, the stock’s Stochastic %D was 61.41%. Additionally, its Average True Range was 2.83.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 78.83%, which indicates a significant increase from 76.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.05% in the past 14 days, which was lower than the 38.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.52, while its 200-day Moving Average is $64.64. However, in the short run, Insmed Inc’s stock first resistance to watch stands at $78.31. Second resistance stands at $80.04. The third major resistance level sits at $81.23. If the price goes on to break the first support level at $75.40, it is likely to go to the next support level at $74.21. Now, if the price goes above the second support level, the third support stands at $72.48.
Insmed Inc (NASDAQ: INSM) Key Stats
There are currently 178,903K shares outstanding in the company with a market cap of 13.70 billion. Presently, the company’s annual sales total 305,210 K according to its annual income of -749,570 K. Last quarter, the company’s sales amounted to 93,430 K and its income totaled -220,520 K.
